Completed PHASE4 INTERVENTIONAL 1-arm NCT03773536

Efficacy and Safety of Artesunate + Amodiaquine With SLD of Primaquine for Treatment of Falciparum Malaria in Zanzibar (AcoV)

Efficacy and Safety of Artesunate + Amodiaquine Combined With a Single Low Dose of Primaquine (0.25 mg/kg) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Zanzibar

Sponsor: Ministry of Health and Social Welfare, Zanzibar

Conditions Plasmodium Falciparum Malaria

Interventions Artesunate-amodiaquine given with single low dose primaquine

Updated 4 times since 2019 Last updated: Dec 10, 2018 Started: May 9, 2017 Primary completion: Sep 25, 2017 Completion: Sep 25, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Plasmodium Falciparum Malaria, this trial is completed. The trial is conducted by Ministry of Health and Social Welfare, Zanzibar and has accumulated 4 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2019 — Jan 2021 [monthly]

Completed PHASE4

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Health and Social Welfare, Zanzibar
Professor Anders Björkman
Uppsala University
Zanzibar Malaria Elimination Programme

Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zanzibar, Tanzania